• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE PROPATEN VASCULAR GRAFT; PROSTHESIS, VASCULAR GRAFT Back to Search Results
Model Number HPT040010A
Device Problem Complete Blockage (1094)
Patient Problems Bacterial Infection (1735); Obstruction/Occlusion (2422); Thrombosis/Thrombus (4440)
Event Date 11/13/2020
Event Type  Injury  
Manufacturer Narrative
Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
The following was reported to gore: on (b)(6) 2020, a patient underwent a right thoracotomy as part of a blalock-taussig shunt procedure utilizing a gore® propaten® vascular graft configured for pediatric shunt device.Physician confirmed all shunts are on prophylactic heparin until they¿re able to transition to aspirin and that aspirin responsiveness is checked in everyone prior to stopping heparin.On the same day as the initial procedure, (b)(6) 2020, evidence of decreasing saturations and echo studies could not confirm shunt patency.A few hours after, no shunt flow could be detected.On the following day, (b)(6) 2020, the shunt is difficult to see by doppler and there doesn't appear to be any flow through it.A thrombectomy was performed and the original shunt remained.Progressive narrowing of the shunt was described with echo beginning on (b)(6), 2021.On (b)(6) 2021 shunt ligation and takedown was performed and purulent material was found around the shunt, which was subtotally thrombosed.Pcr detected staphylococcus epidermidis around the shunt.
 
Manufacturer Narrative
H6: type of investigation, investigation findings, and investigation conclusions updated to reflect completion of investigation.
 
Manufacturer Narrative
Completed sterilization records review: a review of the manufacturing records indicated the lot met all pre-release sterilization specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE PROPATEN VASCULAR GRAFT
Type of Device
PROSTHESIS, VASCULAR GRAFT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
MDR Report Key12011235
MDR Text Key264502401
Report Number2017233-2021-02084
Device Sequence Number1
Product Code DSY
UDI-Device Identifier00733132606276
UDI-Public00733132606276
Combination Product (y/n)Y
PMA/PMN Number
K062161
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup,Followup
Report Date 09/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/16/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/28/2024
Device Model NumberHPT040010A
Device Catalogue NumberHPT040010A
Was Device Available for Evaluation? No
Date Manufacturer Received05/19/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age14 DA
Patient Weight2
-
-